Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance

Background: Postmarketing safety analysis is an effective supplement for new drugs in clinical practice. Therefore, we aimed to systematically assess the safety of oral nemonoxacin malate, the first approved C-8-methoxy non-fluorinated quinolone, in clinical studies and via postmarketing safety surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jinyi, Zhang, Xiaoping, Chen, Jing, Zhang, Yueyuan, Zhu, Fengjia, Huang, Haihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780658/
https://www.ncbi.nlm.nih.gov/pubmed/36569296
http://dx.doi.org/10.3389/fphar.2022.1067686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780658/
https://www.ncbi.nlm.nih.gov/pubmed/36569296
http://dx.doi.org/10.3389/fphar.2022.1067686

Ejemplares similares